Deferoxamine and eflornithine (DL-alpha-difluoromethylornithine) in a rat model of Pneumocystis carinii pneumonia
- PMID: 2285303
- PMCID: PMC171942
- DOI: 10.1128/AAC.34.9.1833
Deferoxamine and eflornithine (DL-alpha-difluoromethylornithine) in a rat model of Pneumocystis carinii pneumonia
Abstract
The iron chelator deferoxamine and the polyamine biosynthesis inhibitor eflornithine (DL-alpha-difluoromethylornithine) were examined for anti-Pneumocystis carinii activity in the rat model of P. carinii pneumonia. The activity of deferoxamine at 250, 500, and 1,000 mg/kg given intraperitoneally provides evidence that iron chelation is a promising novel approach to P. carinii chemotherapy. Results with eflornithine at 2, 3, and 4% in drinking water confirm and extend previously reported activity in the rat model.
Similar articles
-
Efficacy of DL-alpha-difluoromethylornithine in a rat model of Pneumocystis carinii pneumonia.Antimicrob Agents Chemother. 1988 Aug;32(8):1158-63. doi: 10.1128/AAC.32.8.1158. Antimicrob Agents Chemother. 1988. PMID: 3142346 Free PMC article.
-
Pneumocystis carinii pneumonia treated with eflornithine in AIDS patients resistant to conventional therapy.AIDS. 1990 Oct;4(10):1019-21. doi: 10.1097/00002030-199010000-00012. AIDS. 1990. PMID: 2261116
-
Eflornithine versus cotrimoxazole in the treatment of Pneumocystis carinii pneumonia in AIDS patients.AIDS. 1992 Dec;6(12):1489-93. doi: 10.1097/00002030-199212000-00011. AIDS. 1992. PMID: 1492932 Clinical Trial.
-
Treatment of infection due to Pneumocystis carinii.Antimicrob Agents Chemother. 1998 Jun;42(6):1309-14. doi: 10.1128/AAC.42.6.1309. Antimicrob Agents Chemother. 1998. PMID: 9624465 Free PMC article. Review. No abstract available.
-
Eflornithine for the treatment of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome: a preliminary review.Pharmacotherapy. 1989;9(1):29-33. doi: 10.1002/j.1875-9114.1989.tb04100.x. Pharmacotherapy. 1989. PMID: 2493638 Review.
Cited by
-
Ornithine decarboxylase in Pneumocystis carinii and implications for therapy.Antimicrob Agents Chemother. 1994 Nov;38(11):2545-52. doi: 10.1128/AAC.38.11.2545. Antimicrob Agents Chemother. 1994. PMID: 7872745 Free PMC article.
-
Continuous infusion of DL-alpha-difluoromethylornithine and improved efficacy against a rat model of Pneumocystis carinii pneumonia.Antimicrob Agents Chemother. 1996 Oct;40(10):2318-20. doi: 10.1128/AAC.40.10.2318. Antimicrob Agents Chemother. 1996. PMID: 8891137 Free PMC article.
-
Polyamine content of Pneumocystis carinii and response to the ornithine decarboxylase inhibitor DL-alpha-difluoromethylornithine.Antimicrob Agents Chemother. 1996 Apr;40(4):973-8. doi: 10.1128/AAC.40.4.973. Antimicrob Agents Chemother. 1996. PMID: 8849262 Free PMC article.
-
Trophozoite elimination in a rat model of Pneumocystis carinii pneumonia by clinically achievable plasma deferoxamine concentrations.Antimicrob Agents Chemother. 1996 May;40(5):1298-300. doi: 10.1128/AAC.40.5.1298. Antimicrob Agents Chemother. 1996. PMID: 8723489 Free PMC article.
-
Iron metabolism in the lower respiratory tract.Thorax. 1998 Jul;53(7):594-600. doi: 10.1136/thx.53.7.594. Thorax. 1998. PMID: 9797761 Free PMC article. Review. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources